(-0.01%) 5 213.00 points
(-0.02%) 39 021 points
(-0.02%) 18 196 points
(-0.57%) $77.93
(0.32%) $2.21
(0.09%) $2 326.30
(0.28%) $27.62
(-0.20%) $986.40
(0.12%) $0.931
(0.39%) $10.94
(0.18%) $0.801
(-0.03%) $91.41
5 days till quarter result
(bmo 2024-05-13)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials...
Stats | |
---|---|
Today's Volume | 1 000.00 |
Average Volume | 40.00 |
Market Cap | 238.13M |
Next earnings date | ( $0 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 11.67 |
ATR14 | $0.00700 (2.00%) |
Volume Correlation
hVIVO plc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
hVIVO plc Correlation - Currency/Commodity
hVIVO plc Financials
Annual | 2023 |
Revenue: | $56.04M |
Gross Profit: | $7.70M (13.74 %) |
EPS: | $0.0238 |
FY | 2023 |
Revenue: | $56.04M |
Gross Profit: | $7.70M (13.74 %) |
EPS: | $0.0238 |
FY | 2022 |
Revenue: | $48.48M |
Gross Profit: | $4.00M (8.26 %) |
EPS: | $-0.00120 |
Financial Reports:
No articles found.
hVIVO plc
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides preclinical and early clinical research services; sales and marketing services; and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators